CHLOROTHIAZIDE; RESERPINE - Generic Drug Details
What are the generic sources for chlorothiazide; reserpine and what is the scope of freedom to operate?
Chlorothiazide; reserpine
is the generic ingredient in five branded drugs marketed by Hikma, Watson Labs, Pharmobedient, and Merck, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.Summary for CHLOROTHIAZIDE; RESERPINE
| US Patents: | 0 |
| Tradenames: | 5 |
| Applicants: | 4 |
| NDAs: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| DailyMed Link: | CHLOROTHIAZIDE; RESERPINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CHLOROTHIAZIDE; RESERPINE
US Patents and Regulatory Information for CHLOROTHIAZIDE; RESERPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | DIUPRES-250 | chlorothiazide; reserpine | TABLET;ORAL | 011635-003 | Aug 26, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | CHLOROTHIAZIDE W/ RESERPINE | chlorothiazide; reserpine | TABLET;ORAL | 084853-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmobedient | CHLOROTHIAZIDE-RESERPINE | chlorothiazide; reserpine | TABLET;ORAL | 087744-001 | May 6, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Merck | DIUPRES-500 | chlorothiazide; reserpine | TABLET;ORAL | 011635-006 | Aug 26, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
